| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | MRPS4 |
| Uniprot No | Q9NV31 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-184aa |
| 氨基酸序列 | MVRKLKFHEQ KLLKQVDFLN WEVTDHNLHE LRVLRRYRLQ RREDYTRYNQ LSRAVRELAR RLRDLPERDQ FRVRASAALL DKLYALGLVP TRGSLELCDF VTASSFCRRR LPTVLLKLRM AQHLQAAVAF VEQGHVRVGP DVVTDPAFLV TRSMEDFVTW VDSSKIKRHV LEYNEERDDF DLEA |
| 预测分子量 | 21,8 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于MRPS4重组蛋白的参考文献示例(注：部分信息为示例性概括，建议通过学术数据库核实具体文献)：
1. **文献名称**: "Mitochondrial ribosomal protein S4 in cancer progression"
**作者**: Smith A, et al.
**摘要**: 研究MRPS4在肿瘤细胞中的表达调控，发现其重组蛋白通过影响线粒体翻译活性促进肿瘤细胞增殖，并通过敲除实验验证其对线粒体功能的关键作用。
2. **文献名称**: "Structural characterization of recombinant human MRPS4"
**作者**: Zhang L, et al.
**摘要**: 报道人源MRPS4重组蛋白在大肠杆菌中的表达与纯化方法，结合X射线晶体学解析其三维结构，揭示其在线粒体核糖体小亚基组装中的潜在结合位点。
3. **文献名称**: "MRPS4 mutations impair mitochondrial translation and cause developmental disorders"
**作者**: Johnson R, et al.
**摘要**: 通过重组蛋白功能实验，发现MRPS4基因突变导致线粒体蛋白合成缺陷，与神经发育异常相关，为遗传性线粒体疾病的分子机制提供证据。
4. **文献名称**: "Functional interaction between MRPS4 and apoptosis-related proteins"
**作者**: Chen H, et al.
**摘要**: 利用重组MRPS4蛋白进行体外结合实验，证明其与Bcl-2家族蛋白存在相互作用，提示其可能通过调控线粒体途径影响细胞凋亡过程。
**注意**：以上文献信息为示例性概括，实际研究请通过PubMed、Web of Science等平台以"MRPS4"、"recombinant mitochondrial ribosomal protein S4"等关键词检索。
The mitochondrial ribosomal protein S4 (MRPS4) is a key component of the small subunit (28S) of the mitochondrial ribosome (mitoribosome), which is essential for protein synthesis within mitochondria. Encoded by nuclear DNA, MRPS4 is synthesized in the cytoplasm and imported into mitochondria, where it participates in assembling the mitoribosome's structural framework and facilitating the translation of mitochondrial DNA (mtDNA)-encoded mRNAs. These mRNAs primarily code for subunits of the oxidative phosphorylation (OXPHOS) complexes, critical for ATP production. MRPS4’s role in mitochondrial translation links it to cellular energy metabolism, redox balance, and apoptosis regulation.
Recombinant MRPS4 protein is produced using heterologous expression systems, such as *E. coli* or mammalian cell lines, to study its structure, function, and interactions. The recombinant form is often engineered with affinity tags (e.g., His-tag) for purification and detection. Its production enables *in vitro* studies on mitoribosome assembly, mitochondrial translation mechanisms, and mutations associated with mitochondrial disorders. For instance, MRPS4 mutations have been implicated in mitochondrial encephalopathies, cardiomyopathies, and cancer, where impaired OXPHOS leads to metabolic reprogramming.
Research on recombinant MRPS4 also aids in deciphering its potential role in diseases. In cancer, altered mitochondrial ribosome function may drive tumor progression by promoting metabolic adaptation. Additionally, MRPS4 has been explored as a biomarker for mitochondrial dysfunction. Recombinant protein-based assays help screen for therapeutic compounds targeting mitochondrial translation or validate pathogenic variants in genetic studies. Overall, MRPS4 recombinant protein serves as a vital tool for unraveling mitochondrial biology and its implications in health and disease.
×
